Major Hemorrhage Risk Increased Among Older Adults With CKD
ASPREE trial data offered a “unique opportunity” to assess bleeding risk in older populations with and without CKD.
ASPREE trial data offered a “unique opportunity” to assess bleeding risk in older populations with and without CKD.
Furthermore, use of anticoagulants induces higher incidence of GI bleeding in hemodialysis versus peritoneal dialysis patients
GDF-15 adds predictive value to the HAS-BLED score for assessing major bleeding risk.
Patients with acute ischemic stroke and COVID-19 also had worse clinical outcomes, including increased mortality
The increased risk for venous thromboembolism with an arteriovenous graft is one factor for clinicians and patients to consider in the choice of vascular access for hemodialysis.
Apixaban is a direct oral anticoagulant that relies less on kidney excretion.
Rate ratios were highest for critical COVID-19, and during first versus second and third pandemic waves in Sweden
Study is the largest to explore this potential safety issue to date.
There are currently 4 FDA-approved hydroxyethyl starch products on the market.
Intensive BP lowering after intracerebral hemorrhage linked to poorer outcomes in patients with decreased renal function